Cholecystokinin-mediated synaptic function and the treatment of neuropsychiatric disease.

Abstract

Annals of the New York Academy of SciencesVolume 448, Issue 1 p. 553-561 Cholecystokinin-mediated Synaptic Function and the Treatment of Neuropsychiatric Disease T. N. CHASE, T. N. CHASE Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorP. BARONE, P. BARONE Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorG. BRUNO, G. BRUNO Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorS. L. COHEN, S. L. COHEN Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorJ. JUNCOS, J. JUNCOS Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorM. KNIGHT, M. KNIGHT Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorS. RUGGERI, S. RUGGERI Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorL. STEARDO, L. STEARDO Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorC. A. TAMMINGA, C. A. TAMMINGA Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this author T. N. CHASE, T. N. CHASE Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorP. BARONE, P. BARONE Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorG. BRUNO, G. BRUNO Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorS. L. COHEN, S. L. COHEN Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorJ. JUNCOS, J. JUNCOS Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorM. KNIGHT, M. KNIGHT Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorS. RUGGERI, S. RUGGERI Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorL. STEARDO, L. STEARDO Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorC. A. TAMMINGA, C. A. TAMMINGA Experimental Therapeutics Branch National Institute of Neurological and Communication Disorders and Stroke National Institutes of Health Bethesda, Maryland 20205Search for more papers by this author First published: July 1985 https://doi.org/10.1111/j.1749-6632.1985.tb29948.xCitations: 6AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume448, Issue1Neuronal CholecystokininJuly 1985Pages 553-561 RelatedInformation